Immune checkpoint inhibitors in acute myeloid leukemia: a meta-analysis

HIGHLIGHTS

• who: Marina Gó from the Hematology Department, Medical University General Hospital Gregorio Marau00f1on, Madrid, Spain, Health Research Institute have published the article: Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis, in the Journal: (JOURNAL)
• what: The aim of this systematic review and meta-analysis is to assess the efficacy of immune checkpoint inhibitor-based immunotherapy (ICI) in acute myeloid leukemia (AML), either after first-line chemotherapy with allo-HSCT, in refractory or relapsed disease and in patients who are not candidates for intensive chemotherapy who are treated with hypomethylating agents.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.